| Primary |
| Idiopathic Thrombocytopenic Purpura |
61.3% |
| Myelodysplastic Syndrome |
7.9% |
| Thrombocytopenia |
7.5% |
| Prophylaxis |
5.0% |
| Immune Thrombocytopenic Purpura |
3.7% |
| Drug Use For Unknown Indication |
2.9% |
| Hypertension |
1.8% |
| Gastrointestinal Haemorrhage |
1.6% |
| Product Used For Unknown Indication |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Infection |
0.8% |
| Thrombocytopenic Purpura |
0.8% |
| Adenocarcinoma |
0.6% |
| Chemotherapy |
0.6% |
| Insomnia |
0.6% |
| Anaemia |
0.5% |
| Autoimmune Thrombocytopenia |
0.5% |
| Cardiac Failure |
0.5% |
| Colon Cancer |
0.5% |
| Constipation |
0.5% |
|
| Thrombocytopenia |
12.6% |
| Pulmonary Embolism |
9.0% |
| Drug Ineffective |
8.0% |
| Myelofibrosis |
7.5% |
| Therapeutic Response Decreased |
7.5% |
| Haemorrhage |
6.5% |
| Deep Vein Thrombosis |
5.5% |
| Venous Thrombosis |
5.5% |
| Overdose |
4.0% |
| Phlebitis |
3.5% |
| Platelet Count Decreased |
3.5% |
| Transient Ischaemic Attack |
3.5% |
| Vaginal Haemorrhage |
3.5% |
| Myocardial Infarction |
3.0% |
| Neutropenia |
3.0% |
| Septic Shock |
3.0% |
| Thrombosis |
3.0% |
| Chronic Lymphocytic Leukaemia |
2.5% |
| Diarrhoea |
2.5% |
| Sudden Death |
2.5% |
|
| Secondary |
| Idiopathic Thrombocytopenic Purpura |
38.1% |
| Prophylaxis |
12.5% |
| Product Used For Unknown Indication |
8.8% |
| Chronic Obstructive Pulmonary Disease |
7.6% |
| Hypertension |
5.5% |
| Insomnia |
4.3% |
| Haematology Test Abnormal |
3.4% |
| Antiemetic Supportive Care |
2.9% |
| Gastrooesophageal Reflux Prophylaxis |
2.8% |
| Pneumonia Aspiration |
2.2% |
| Pruritus |
2.2% |
| Myelodysplastic Syndrome |
1.7% |
| Thrombocytopenia |
1.6% |
| Foetal Exposure Timing Unspecified |
1.3% |
| Immune Thrombocytopenic Purpura |
1.3% |
| Thrombocytosis |
1.1% |
| Cardiac Failure |
0.7% |
| Foetal Exposure During Pregnancy |
0.7% |
| Labour Induction |
0.7% |
| Autoimmune Thrombocytopenia |
0.5% |
|
| Epistaxis |
14.0% |
| Neutropenia |
14.0% |
| Biopsy Bone Marrow Abnormal |
8.2% |
| Clostridium Colitis |
7.0% |
| Gastric Ulcer |
7.0% |
| Constipation |
5.3% |
| Red Blood Cell Count Decreased |
5.3% |
| Purpura |
4.7% |
| Vaginal Haemorrhage |
4.7% |
| Melaena |
3.5% |
| Pulmonary Embolism |
3.5% |
| Renal Impairment |
3.5% |
| Leukocytosis |
2.9% |
| Thrombocytosis |
2.9% |
| Haemoglobin Decreased |
2.3% |
| Haemorrhage |
2.3% |
| Hypothyroidism |
2.3% |
| Therapeutic Response Decreased |
2.3% |
| Thrombocytopenia |
2.3% |
| Hepatic Function Abnormal |
1.8% |
|
| Concomitant |
| Idiopathic Thrombocytopenic Purpura |
64.9% |
| Product Used For Unknown Indication |
14.8% |
| Thrombocytopenia |
2.6% |
| Autoimmune Thrombocytopenia |
2.1% |
| Aplastic Anaemia |
1.6% |
| Drug Use For Unknown Indication |
1.6% |
| Arthralgia |
1.3% |
| Depression |
1.3% |
| Diffuse Large B-cell Lymphoma |
1.3% |
| Insomnia |
1.0% |
| Lupus-like Syndrome |
1.0% |
| Portal Hypertension |
1.0% |
| Crohn's Disease |
0.8% |
| Hepatitis C |
0.8% |
| Ill-defined Disorder |
0.8% |
| Nausea |
0.8% |
| Pulmonary Arterial Hypertension |
0.8% |
| Anxiety |
0.5% |
| Pain |
0.5% |
| Paroxysmal Nocturnal Haemoglobinuria |
0.5% |
|
| Drug Ineffective |
20.3% |
| Death |
9.5% |
| Progressive Multifocal Leukoencephalopathy |
6.8% |
| Infection |
5.4% |
| Acute Myeloid Leukaemia |
4.1% |
| Adverse Event |
4.1% |
| Cardiac Disorder |
4.1% |
| Deep Vein Thrombosis |
4.1% |
| Haematological Malignancy |
4.1% |
| Myelofibrosis |
4.1% |
| Platelet Count Decreased |
4.1% |
| Pruritus |
4.1% |
| Reticulocytosis |
4.1% |
| Suicidal Ideation |
4.1% |
| Thrombocytopenia |
4.1% |
| Colon Cancer |
2.7% |
| Haemorrhage |
2.7% |
| Headache |
2.7% |
| Hepatic Failure |
2.7% |
| Idiopathic Thrombocytopenic Purpura |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
| Drug Interaction |
50.0% |
| Surgery |
33.3% |
| Platelet Count Decreased |
16.7% |
|
